AK

Abhishek Kuberchand Patwa

Active Director Director DIN 11050144
DIN 11050144 First appointment Apr 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Abhishek Kuberchand Patwa

Data last updated:

Abhishek Kuberchand Patwa is a Director at Elton Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11050144
Primary Designation Director
Industry Pharma
First Appointment 10 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Apr 20252025Active

Board colleagues of Abhishek Kuberchand Patwa

NameDINCompanyDesignation
Mohit Kumar Patwa11050145Elton Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Elton Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Abhishek Kuberchand Patwa

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhishek Kuberchand Patwa

Abhishek Kuberchand Patwa currently holds 1 directorship: Elton Pharmaceuticals Private Limited (Director, since 10 Apr 2025).

Abhishek Kuberchand Patwa was first appointed on 10 Apr 2025 as Director at Elton Pharmaceuticals Private Limited.

The current boards of Abhishek Kuberchand Patwa's companies include Mohit Kumar Patwa (Elton Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available